Skip to main content
SpringerLink
Log in

Reproductive Endocrinology and Infertility

  • Chapter
  • First Online:
Handbook of Consult and Inpatient Gynecology

  • 1000 Accesses

Abstract

Up to 15 % of couples experience infertility; this chapter provides an overview of reproductive endocrinology care, including ovulation induction and in vitro fertilization. The differential diagnosis of vaginal bleeding, abdominal pain, and adnexal masses in this specific patient population is discussed. The diagnosis and management of complications of infertility care—including ovarian hyperstimulation syndrome (OHSS), pelvic infections, ovarian torsion and ectopic pregnancy—are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Practice Committee of American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril. 2013;99:63.

    Google Scholar 

  2. Thoma ME, McLain AC, Louis JF, King RB, Trumble AC, Sundaram R, et al. Prevalence of infertility in the United States as estimated by the current duration approach and a traditional constructed approach. Fertil Steril. 2013;99:1324–31.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hoffman BL, Schorge JO, Schaffer JI, Halvorson LM, Bradshaw KD, Cunningham F, et al. Chapter 20. Treatment of the infertile couple. In Hoffman BL, Schorge JO, Schaffer JI, Halvorson LM, Bradshaw KD, Cunningham F, Calver LE, editors. Williams gynecology. 2nd edn. New York: McGraw-Hill; 2012. http://accessmedicine.mhmedical.com.ezp-prod1.hul.harvard.edu/content.aspx?bookid=399&Sectionid=41722309. Accessed 02 June 2015.

  4. Purvin VA. Visual disturbance secondary to clomiphene citrate. Arch Ophthalmol. 1995;113:482–4.

    Article  CAS  PubMed  Google Scholar 

  5. Practice Committee of the American Society for Reproductive Medicine. Use of clomiphene citrate in infertile women: a committee opinion. Fertil Steril. 2013;100:341–8.

    Article  Google Scholar 

  6. Mitchell SY, Fletcher HM, Williams E. Ovarian hyperstimulation syndrome associated with clomiphene citrate. West Indian Med J. 2001;50:227–9.

    CAS  PubMed  Google Scholar 

  7. Sacks PC, Simon JA. Infectious complications of intrauterine insemination: a case report and literature review. Int J Fertil. 1991;36:331–9.

    CAS  PubMed  Google Scholar 

  8. Weissman A, Lurie S, Zalel Y, Goldchmit R, Shoham Z. Human chorionic gonadotropin: pharmacokinetics of subcutaneous administration. Gynecol Endocrinol. 1996;10:273–6.

    Article  CAS  PubMed  Google Scholar 

  9. Mannaerts BM, Geurts TB, Odink J. A randomized three-way cross-over study in healthy pituitary-suppressed women to compare the bioavailability of human chorionic gonadotrophin (Pregnyl) after intramuscular and subcutaneous administration. Hum Reprod. 1998;13:1461–4.

    Article  CAS  PubMed  Google Scholar 

  10. Barnhart K. Ectopic pregnancy. N Engl J Med. 2009;361:379–87.

    Article  CAS  PubMed  Google Scholar 

  11. Practice Committee of the American Society for Reproductive Medicine. Medical treatment of ectopic pregnancy: a committee opinion. Fertil Steril. 2013;100:638–44.

    Article  Google Scholar 

  12. Bodri D, Guillén JJ, Polo A, Trullenque M, Esteve C, Coll O. Complications related to ovarian stimulation and oocyte retrieval in 4052 oocyte donor cycles. Reprod Biomed Online. 2008;17:237–43.

    Article  PubMed  Google Scholar 

  13. Ragni G, Scarduelli C, Calanna G, Santi G, Benaglia L, Somigliana E. Blood loss during transvaginal oocyte retrieval. Gynecol Obstet Invest. 2009;67:32–5.

    Article  PubMed  Google Scholar 

  14. Dessole S, Rubattu G, Ambrosini G, Miele M, Nardelli GB, Cherchi PL. Blood loss following noncomplicated transvaginal oocyte retrieval for in vitro fertilization. Fertil Steril. 2001;76:205–6.

    Article  CAS  PubMed  Google Scholar 

  15. Bolster F, Mocanu E, Geoghegan T, Lawler L. Transvaginal oocyte retrieval complicated by life-threatening obturator artery haemorrhage and managed by a vessel-preserving technique. Ulster Med J. 2014;83:146–8.

    PubMed  PubMed Central  Google Scholar 

  16. Nouri K, Walch K, Promberger R, Kurz C, Tempfer CB, Ott J. Severe haematoperitoneum caused by ovarian bleeding after transvaginal oocyte retrieval: a retrospective analysis and systematic literature review. Reprod Biomed Online. 2014;29:699–707.

    Article  PubMed  Google Scholar 

  17. Roest J, Mous HV, Zeilmaker GH, Verhoeff A. The incidence of major clinical complications in a Dutch transport IVF programme. Hum Reprod Update. 1996;2:345–53.

    Article  CAS  PubMed  Google Scholar 

  18. Ludwig AK, Glawatz M, Griesinger G, Diedrich K, Ludwig M. Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: prospective study of >1000 oocyte retrievals. Hum Reprod. 2006;21:3235–40.

    Article  CAS  PubMed  Google Scholar 

  19. Somigliana E, Benaglia L, Paffoni A, Busnelli A, Vigano P, Vercellini P. Risks of conservative management in women with ovarian endometriomas undergoing IVF. Hum Reprod Update. 2015;21:486–99.

    Article  PubMed  Google Scholar 

  20. Practice Committee of American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2008;90:S188–93.

    Google Scholar 

  21. Delvigne A. Symposium: update on prediction and management of OHSS. Epidemiology of OHSS. Reprod Biomed Online. 2009;19:8–13.

    Article  PubMed  Google Scholar 

  22. Levin ER, Rosen GF, Cassidenti DL, Yee B, Meldrum D, Wisot A, et al. Role of vascular endothelial cell growth factor in Ovarian Hyperstimulation Syndrome. J Clin Invest. 1998;102:1978–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Delvigne A, Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update. 2003;9:77–96.

    Article  CAS  PubMed  Google Scholar 

  24. Neulen J, Yan Z, Raczek S, Weindel K, Keek C, Weich HA, et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab. 1995;80:1967–71.

    CAS  PubMed  Google Scholar 

  25. Rova K, Passmark H, Lindqvist PG. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril. 2012;97:95–100.

    Article  PubMed  Google Scholar 

  26. Papanikolaou EG, Pozzobon C, Kolibianakis EM, Camus M, Tournaye H, Fatemi HM, et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2006;85:112–20.

    Article  CAS  PubMed  Google Scholar 

  27. Asch RH, Li HP, Balmaceda JP, Weckstein LN, Stone SC. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups. Hum Reprod. 1991;6:1395–9.

    CAS  PubMed  Google Scholar 

  28. Lee TH, Liu CH, Huang CC, Wu YL, Shih YT, Ho HN, et al. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod. 2008;23:160–7.

    Article  CAS  PubMed  Google Scholar 

  29. Enskog A, Henriksson M, Unander M, Nilsson L, Brännström M. Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 1999;71:808–14.

    Article  CAS  PubMed  Google Scholar 

  30. Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, et al. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril. 2009;92:1586–93.

    Article  CAS  PubMed  Google Scholar 

  31. Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I. Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. J Assist Reprod Genet. 2011;28:1197–203.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, et al. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev. 2014;(10):CD008046.

    Google Scholar 

  33. Mathur RS, Akande AV, Keay SD, Hunt LP, Jenkins JM. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril. 2000;73:901–7.

    Article  CAS  PubMed  Google Scholar 

  34. Scalea TM, Rodriguez A, Chiu WC, Brenneman FD, Fallon Jr WF, Kato K, et al. Focused Assessment with Sonography for Trauma (FAST): results from an international consensus conference. J Trauma. 1999;46:466–72.

    Article  CAS  PubMed  Google Scholar 

  35. Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril. 1992;58:249–61.

    Article  CAS  PubMed  Google Scholar 

  36. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989;44:430–40.

    Article  CAS  PubMed  Google Scholar 

  37. Mathur R, Evbuomwan I, Jenkins J. Prevention and management of ovarian hyperstimulation syndrome. Curr Obstet Gynaecol. 2005;15:132–8.

    Article  Google Scholar 

  38. Granberg S, Gjelland K, Ekerhovd E. The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol. 2009;23:667–78.

    Article  PubMed  Google Scholar 

  39. Noone TC, Semelka RC, Worawattanakul S, Marcos HB. Intraperitoneal abscesses: diagnostic accuracy of and appearances at MR imaging. Radiology. 1998;208:525–8.

    Article  CAS  PubMed  Google Scholar 

  40. Yaron Y, Peyser MR, Samuel D, Amit A, Lessing JB. Infected endometriotic cysts secondary to oocyte aspiration for in-vitro fertilization. Hum Reprod. 1994;9:1759–60.

    CAS  PubMed  Google Scholar 

  41. Mais V, Guerriero S, Ajossa S, Angiolucci M, Paoletti AM, Melis GB. The efficiency of transvaginal ultrasonography in the diagnosis of endometrioma. Fertil Steril. 1993;60:776–80.

    Article  CAS  PubMed  Google Scholar 

  42. Heilbrun ME, Olpin J, Shaaban A. Imaging of benign adnexal masses: characteristic presentations on ultrasound, computed tomography, and magnetic resonance imaging. Clin Obstet Gynecol. 2009;52:21–39.

    Article  PubMed  Google Scholar 

  43. Rackow BW, Patrizio P. Successful pregnancy complicated by early and late adnexal torsion after in vitro fertilization. Fertil Steril. 2007;87:697.e9–12.

    Google Scholar 

  44. Kart C, Guven S, Aran T, Dinc H. Life-threatening intraabdominal bleeding after oocyte retrieval successfully managed with angiographicembolization. Fertil Steril. 2011;96:e99–102.

    Article  PubMed  Google Scholar 

  45. Aboulghar MA, Mansour RT, Serour GI, Rizk B. Ultrasonic transvaginal aspiration of endometriotic cysts: an optional line of treatment in selected cases of endometriosis. Hum Reprod. 1991;6:1408–10.

    CAS  PubMed  Google Scholar 

  46. Chan LY, So WW, Lao TT. Rapid recurrence of endometrioma after transvaginal ultrasound-guided aspiration. Euro J Obstet Gynecol Reprod Biol. 2003;109:196–8.

    Article  Google Scholar 

  47. Alborzi S, Zarei A, Alborzi S, Alborzi M. Management of ovarian endometrioma. Clin Obstet Gynecol. 2006;49:480–91.

    Article  PubMed  Google Scholar 

  48. Nishida M, Watanabe K, Sato N, Ichikawa Y. Malignant transformation of ovarian endometriosis. Gynecol Obstet Invest. 2000;50:18–25.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, USA

    Paula C. Brady MD & Elizabeth S. Ginsburg MD

Authors
  1. Paula C. Brady MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth S. Ginsburg MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paula C. Brady MD .

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Brady, P.C., Ginsburg, E.S. (2016). Reproductive Endocrinology and Infertility. In: Handbook of Consult and Inpatient Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-27724-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27724-0_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27722-6

  • Online ISBN: 978-3-319-27724-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation